Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42204420
Type of Stem Cell Treatment:
Diseases:
Chronic Lymphocytic Leukaemia (CLL)
Short title:
Primary objective:
Key inclusion criteria:
>18 years old; CLL; ast or 2nd PR or CR at time of transplant
Country:
Principal investigator:
Johannes Schetelig
EBMT Study coordinator:
Jennifer Hoek